Audited Financial Results for the Quarter and Year ended 31.03.2026

Qualified OpinionRevenue Growth 20pctRelated Party TransactionsNegative Operating CashflowResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+6.2%1-day move

₹28.19

prior close

₹27.70

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+2.0+2.0+4.7+4.5+6.2+1.1-0.3+2.4-0.7-0.3+6.1-11.0——

Up moveDown movePending

AI summary

Bandaram Pharma Packtech Ltd reported standalone revenue of Rs. 6,292.32 lakhs for FY2026, up 70% from Rs. 3,696.38 lakhs in FY2025. However, standalone net profit fell 55% to Rs. 44.81 lakhs from Rs. 99.38 lakhs, indicating cost growth outpaced revenue. Consolidated revenue grew to Rs. 6,294.12 lakhs but net profit dropped 79% to Rs. 28.15 lakhs from Rs. 131.61 lakhs. The standalone auditor gave an unmodified (clean) opinion, but the consolidated auditor issued a qualified opinion due to subsidiary VSR Paper and Packaging Ltd netting off trade receivables and payables without adequate supporting documentation, raising questions about transaction validity. The company appointed M/s. MGR & Co. as internal auditors for FY2026-27.

Likely market impact

The clean standalone audit is positive, but the qualified consolidated opinion flags internal control weaknesses at the subsidiary level, which raises red flags for investors and may pressure the stock price, especially given the sharp profit decline despite strong revenue growth.